[Ip-health] MSF: Untangling the web of ARV prices (2014)

Sharonann Lynch sharonann.lynch at gmail.com
Mon Jul 28 08:28:05 PDT 2014

Apologies ­ the link below is to the 2014 report:


On 7/28/14, 11:08 AM, "Sharonann Lynch" <sharonann.lynch at gmail.com> wrote:

> All, 
> The latest edition of Untangling the Web of Antiretroviral Price Reductions is
> now available here:
> https://www.msfaccess.org/our-work/hiv-aids/article/2084
> The 16th edition of Untangling the Web finds that although the price of first-
> and second-line ARVs have come down thanks to increased generic competition,
> third-line or salvage regimens remain exorbitantly priced, with middle-income
> countries such as Armenia paying more than US$13,000 per person per year for
> raltegravir, just one of the three or four drugs needed in a third-line
> cocktail.
> Patents remain a barrier on newer drugs and in middle-income countries, and
> will need to be overcome to ensure future access to them.

More information about the Ip-health mailing list